Target intelligence / Profile preview

DPP10 antisense RNA 3 (DPP10-AS3)

Target: DPP10-AS3
Molecular classification: Long noncoding RNA (lncRNA), Noncoding RNA

Overview

DPP10 antisense RNA 3 (DPP10-AS3) is a long noncoding RNA transcribed from the antisense strand at the DPP10 locus on chromosome 2 (chr2:114,828,428–)[3]. There is currently no direct evidence for its function, disease association, or potential as a therapeutic target. The scientific literature and genomic databases primarily describe it as a noncoding RNA gene, and no pharmacological agents targeting DPP10-AS3 are known. The functional characterization, disease roles, and clinical relevance remain to be elucidated.

Mechanism of action

Not applicable, as no drug interactions are reported.

Biological functions

The specific functional characterization of DPP10-AS3 is currently lacking in the scientific literature[3]. By analogy to other antisense RNAs in the DPP10 locus family (such as DPP10-AS1), potential biological roles may include gene expression regulation, but this is not confirmed for DPP10-AS3 specifically.

Disease associations

There are currently no disease associations reported for DPP10-AS3. Other lncRNAs at the DPP10 locus (e.g., DPP10-AS1) have been implicated in cancer, but there are no data for DPP10-AS3[3].

Safety considerations

No notable safety concerns or therapeutic challenges are identified, as this is not a recognized drug target.

Biomarkers

There is no evidence that DPP10-AS3 is used as a biomarker for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on DPP10 antisense RNA 3 (DPP10-AS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DPP10 antisense RNA 3 (DPP10-AS3).

Explore the full profile